Cite

HARVARD Citation

    Deodato, M. et al. (2022). How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. Leukemia & lymphoma. 63 (8), pp. 1985-1988. [Online]. 
  
Back to record